Answers are grounded in this paper and cite their sources.
Demonstrates that silencing SOX2 reduces beta-glycerophosphate-induced vascular calcification in human aortic smooth muscle cells, indicating a regulatory role for the Wnt signaling pathway.
Background SRY-box transcription factor 2 ( SOX2 ) is implicated in diverse pathological conditions; however, its contribution to vascular calcification (VC) is not well define. This research explored the influence of SOX2 on VC and associated molecular mechanisms utilizing a β-Glycerophosphate (β-GP)-driven calcification model in human aortic vascular smooth muscle cell (HA-VSMC). Results One in vitro VC model was established by exposing HA-VSMCs to β-GP. The experimental design comprised several key groups: an untreated control, a β-GP-induced calcification model group, a group receiving β-GP and SOX2 -targeting siRNA (si- SOX2 ), a group treated with β-GP and 3-Methyladenine (3-MA), an autophagy inhibitor, and a group co-treated with β-GP, si- SOX2 , and the Wnt pathway activator BML-284. Relative to controls, the β-GP model group exhibited increased calcification, elevated protein levels of SOX2 and osteogenic markers (Runx2, BMP2), enhanced autophagic activity, reduced expression of contractile markers (SM22α, α-SMA), and suppression of Wnt pathway signaling. Transfection with si- SOX2 significantly counteracted these β-GP-induced alterations. Conversely, the beneficial impact of si- SOX2 on β-GP-induced VC was negated by BML-284-mediated activation of the Wnt pathway. Conclusion The findings indicate that suppressing SOX2 alleviates β-GP-induced VC by influencing the activation status of the Wnt pathway.
No takes yet. Share an insight, caveat, or question.
Xiang et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: